1. Show article details.

    Legal Cannabis' Spread Around the Globe Highlights Shift in Opinion

    PR Newswire – 9:00 AM ET 08/13/2020

    NEW YORK, Aug. 13, 2020 Earlier last year, New York state decriminalized the recreational use of cannabis. In recent years, cannabidiol-based products have swiftly emerged.

  2. Show article details.

    Cannabis industry readies for M&A after COVID-19 boosts weed demand

    Reuters – 2:02 PM ET 08/11/2020

    - After nearly a year of next-to-no deal-making, cannabis companies are gearing up for mergers and acquisitions as realistic stock valuations and the prospect of U.S. legalization attract buyers to a sector that has been decimated by oversupply and other issues, executives and investors say.

  3. Show article details.

    Cannabis industry readies for M&A after COVID-19 boosts weed demand

    Reuters – 1:58 PM ET 08/11/2020

    After nearly a year of next-to-no deal-making, cannabis companies are gearing up for mergers and acquisitions as realistic stock valuations and the prospect of U.S. legalization attract buyers to a sector that has been decimated by oversupply and other issues, executives and investors say.

  4. Show article details.

    Pot producer Aphria posts bigger-than-expected loss, shares tumble

    Reuters – 8:12 AM ET 07/29/2020

    Canadian pot producer Aphria (APHA) on Wednesday posted a bigger-than-expected quarterly loss and took impairment charges on some foreign assets, sending shares plunging 17%. The COVID-19 pandemic has caused supply issues and delays in new product launches for cannabis producers as countries close their borders, companies scale back their workforce and the absence of tourism-related dollars adds to th...

  5. Show article details.

    Pot producer Aphria sales surge during coronavirus lockdowns

    Reuters – 7:31 AM ET 07/29/2020

    Canadian pot producer Aphria Inc (APHA) said on Wednesday net revenue rose more than 18% in the fourth quarter, as coronavirus-related lockdowns led to a surge in demand for marijuana. The company, however, swung to a quarterly loss of C$98.8 million, or 39 Canadian cents per share, in the three months ended May 31, compared to a profit of C$15.8 million, or 5 Canadian cents per share, a year ago.

  6. Show article details.

    Aurora Cannabis Appoints International Consumer Packaged Goods Executive Miguel Martin as Chief Commercial Officer

    PR Newswire – 7:00 AM ET 07/06/2020

    NYSE | TSX: ACB. EDMONTON, AB, July 6, 2020  Aurora Cannabis Inc. (ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Miguel Martin, President of Aurora USA and head of Reliva, LLC, has been appointed Chief Commercial Officer of Aurora, effective immediately.

  7. Show article details.

    BRIEF-Aurora Cannabis Announces Retirement Of Terry Booth From Board

    Reuters – 7:03 AM ET 06/29/2020

    Aurora Cannabis Inc (ACB): * AURORA CANNABIS ANNOUNCES RETIREMENT OF TERRY BOOTH FROM BOARD OF DIRECTORS. * Aurora Cannabis Inc (ACB) - CO-FOUNDER TERRY BOOTH HAS RETIRED FROM HIS ROLE AS DIRECTOR, EFFECTIVE JUNE 26 Source text for Eikon: Further company coverage:

  8. Show article details.

    Aurora Cannabis Announces Retirement of Terry Booth from Board of Directors

    PR Newswire – 7:00 AM ET 06/29/2020

     NYSE | TSX: ACB. EDMONTON, AB, June 29, 2020  Aurora Cannabis Inc. , the Canadian company defining the future of cannabinoids worldwide, today announced that Co-Founder Terry Booth has retired from his role as Director of the Company, effective June 26, 2020.

  9. Show article details.

    PRESS DIGEST-Canada - June 24

    Reuters – 6:34 AM ET 06/24/2020

    The following are the top stories from selected Canadian newspapers. THE GLOBE AND MAIL.

  10. Show article details.

    Aurora Cannabis plans more layoffs, facility closures amid industry turmoil

    Reuters – 11:54 AM ET 06/23/2020

    Aurora Cannabis (ACB) on Tuesday announced a new round of staff reductions and plans to shut five facilities over the next two quarters, as the COVID-19 pandemic pummels the cash-crunched cannabis industry.

  11. Show article details.

    Aurora Cannabis plans more layoffs, facility closures amid industry turmoil

    Reuters – 11:35 AM ET 06/23/2020

    - Aurora Cannabis (ACB) on Tuesday announced a new round of staff reductions and plans to shut five facilities over the next two quarters, as the COVID-19 pandemic pummels the cash-crunched cannabis industry.

  12. Show article details.

    Pot company Aurora Cannabis plans layoffs, closing five facilities

    Reuters – 11:26 AM ET 06/23/2020

    Aurora Cannabis (ACB) said on Tuesday it will lay off a big part of its workforce and plans to shut five facilities over the next two quarters, as the cash-crunched cannabis industry finds itself scrambling to cut costs amid the coronavirus pandemic.

  13. Show article details.

    BRIEF-Aurora Cannabis Provides Key Updates On Business Transformation Plan

    Reuters – 11:26 AM ET 06/23/2020

    Aurora Cannabis Inc (ACB): * AURORA CANNABIS PROVIDES KEY UPDATES ON BUSINESS TRANSFORMATION PLAN. * Aurora Cannabis Inc (ACB) - REMAINS ON TRACK FOR POSITIVE ADJUSTED EBITDA IN FISCAL Q1 2021. * AURORA CANNABIS (ACB) - EXITING FISCAL Q4 2020 AT AN SG&A RUN RATE OF APPROXIMATELY $42 MILLION. * Aurora Cannabis Inc (ACB) - CHANGES INCLUDE AN APPROXIMATE 25% REDUCTION IN AURORA'S SG&A STAFF, MOST WITH IMMEDIATE EFFECT.

  14. Show article details.

    Aurora Cannabis Provides Key Updates on Business Transformation Plan

    PR Newswire – 11:10 AM ET 06/23/2020

    NYSE | TSX: ACB. EDMONTON, AB, June 23, 2020 /PRNewswire/ - Aurora Cannabis Inc. (ACB), the Canadian company defining the future of cannabinoids worldwide, today provided a progress update on its Business Transformation Plan that was previously communicated February 6, 2020.

  15. Show article details.

    BRIEF-Aurora Cannabis Announces Retirement Of Co-Founder And President Steve Dobler

    Reuters – 7:13 AM ET 06/16/2020

    Aurora Cannabis Inc (ACB): * AURORA CANNABIS ANNOUNCES RETIREMENT OF CO-FOUNDER AND PRESIDENT STEVE DOBLER. * Aurora Cannabis Inc (ACB) - CO-FOUNDER STEVE DOBLER, WILL RETIRE AS PRESIDENT AND DIRECTOR EFFECTIVE JUNE 30. * Aurora Cannabis Inc (ACB) - WITH RETIREMENT OF DOBLER, BOARD CURRENTLY HAS 9 DIRECTORS Source text for Eikon: Further company coverage:

  16. Show article details.

    Aurora Cannabis Announces Retirement of Co-Founder and President Steve Dobler

    PR Newswire – 7:00 AM ET 06/16/2020

    NYSE | TSX: ACB. EDMONTON, AB, June 16, 2020  Aurora Cannabis Inc. (ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Co-Founder Steve Dobler, will retire from his roles as President and Director of the Company, effective June 30, 2020. Mr. Dobler has been the President of Aurora and a member of Aurora's Board of Directors since December 2014.

  17. Show article details.

    Positive First Steps Show the Promise of Psychedelic Therapies

    PR Newswire – 9:00 AM ET 06/10/2020

    NEW YORK, June 10, 2020 Depression and PTSD are serious psychiatric disorders which happen to share some similar symptoms. Now, years later, new data continues to indicate that psychedelics could be used for legitimate medical purposes.

  18. Show article details.

    Psychedelics Seek to Emulate Cannabis' Medical Legalization Model

    PR Newswire – 9:00 AM ET 06/04/2020

    NEW YORK, June 4, 2020 According to data provided by the World Health Organization, depression is a common illness worldwide, with an estimated 264 million people affected. Whether or not psychedelic products will achieve the same success as cannabis products remains to be seen.

  19. Show article details.

    Psychedelic Products Represent a New Frontier for Mental Health

    PR Newswire – 9:00 AM ET 06/04/2020

    NEW YORK, June 4, 2020 Psychedelic products for medical purposes, specifically for psychiatric conditions, are becoming rapidly more prevalent. The similarities between the potentially upcoming psychedelic industry and the cannabis industry are numerous and clear. Numinus Wellness Inc.  announced last week, "its near-term goals to advance our mission to address the universal desire to heal.

  20. Show article details.

    BRIEF-Alcanna Announces $27.6 Mln Secondary Bought Deal Offering By Aurora Cannabis

    Reuters – 8:04 AM ET 06/03/2020

    Alcanna Inc (LQSIF): * Alcanna Inc (LQSIF). ANNOUNCES $27.6 MILLION SECONDARY BOUGHT DEAL OFFERING BY AURORA CANNABIS INC. * ALCANNA - ENTERED AGREEMENT PURSUANT TO WHICH UNDERWRITERS HAVE AGREED TO PURCHASE 9.2 MILLION COMMON SHARES OF CO CURRENTLY HELD BY AURORA.

Page:

Today's and Upcoming Events

  • Sep
    09

    ACB to announce Q4 earnings (Unconfirmed)

Past Events (last 90 days)

  • May
    14

    ACB announced Q3 earnings.

Data provided by Thomson Reuters © 2020

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.